The results of the study suggested the potential use of Nef as a therapeutic agent in ARDS induced by gram-negative bacterial infections and increased our knowledge about the mechanisms of endothelial glycocalyx protection/restoration. Here, S100B is linked to gram-negative bacterial infections.